Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

INDP Relative to the S&P 500

INDP Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Indaptus Therapeutics Inc (NASD:INDP) seasonal charts above shows that a Buy Date of July 27 and a Sell Date of October 18 has resulted in a geometric average return of 13.38% above the benchmark rate of the S&P 500 Total Return Index over the past 12 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 12 years by an average of 58.79% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. The firm created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.

To download INDP seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: INDP